definiens: shall mean that one or more Licensed Products covered by each Commercial T herapeutic License are in, defined as that at any given time dur ing development, CENTOCOR or its Affiliate or its Sublicensee will be diligently eng aging in one or more of the following activities relating to the development of a Licensed Product : formulation development, study / protocol design, efforts relating to obtaining protocol appr oval by applicable institutional review board of relevant regulatory authority or administration, patient recruitment, patient treatment, data analysis, report writing for any clinical trial, re gulatory filing preparation, pricing or marketing approval preparation, submission to or awaiting rev iew or approval by a regulatory authority or administration, manufacturing or process developmen t, manufacturing scale up, validation or preparation, preclinical or in vitro characterizati on and go / no go decision await ed from a formal research and development committee within CENTOCOR, an Affiliate or an oversite Johnson and Johnson management committee to initiate any of the preceding activities, wherein said Active Development is occurring for at least one Li censed Therapeutic Antibody Product with respect 21 of 124 * * * Confidential Treatment Requested CONFIDENTIAL to each license granted under Section 3.3(a ) . CENTO COR shall be deemed to be diligently exercising such Commercially Reasonable Efforts wit h respect to each Section 3.3(a ) license if CENTOCOR, or an Affiliate or any Sublicensee is in such Active Development ; otherwise, MORPHOSYS shall be permitted to pursue its rights u nder Section 9.3 . For each license granted to CENTOCOR under Section 3.3(a ) for which the fee under Section 5.1(b ) has been paid, CENTOCOR shall provide to MORPHOSYS, upon wri tten request, a development summary report covering ( i ) the past six ( 6 ) months of development activity, which can include meeting minutes from CENTOCOR researc h committee meetings or additional reports ; and ( ii ), to the extent available, an estimated development p lan for the forthcoming six ( 6 ) months